Test Price
2,800 AED✅ Home Collection Available
TGFB1 Gene Camurati‑Engelmann Disease Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TGFB1 لمرض كاموراتي‑إنجلمان في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Your Diagnostic Guarantee
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited Next‑Generation Sequencing (NGS).
- Premium Logistics: Hospital‑grade home collection with ISO‑certified cold‑chain transport and VIP mobile phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test interpretation by a DHA‑licensed genetic specialist.
- Insurance: Direct billing verification – WhatsApp +971 54 548 8731.
ضمان تشخيصي فائق
دقة تشخيصية 99.9% عبر تسلسل الجيل التالي المعتمد من ISO. خدمة سحب منزلي بمعايير المستشفيات مع نقل مبرّد معتمد، وإمكانية التوجيه السريري الهاتفي بعد النتيجة. تحقيق مباشر للتغطية التأمينية عبر الواتساب.
1. Test Overview
This advanced DNA test analyses the entire coding region of the TGFB1 gene using Next‑Generation Sequencing to confirm or exclude Camurati‑Engelmann disease (progressive diaphyseal dysplasia). يفحص هذا الاختبار الجيني طفرات جين TGFB1 لتأكيد تشخيص مرض كاموراتي‑إنجلمان بدقة عالية.
| Feature | Our TGFB1 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Full gene coverage, detects all variant types (SNVs, indels) with 99.9% sensitivity | Targeted exon analysis only; may miss deep intronic or large rearrangements |
| Methodology | NGS (Next‑Generation Sequencing) – Illumina platform, ISO 9001:2015 lab | Sanger sequencing, lower throughput |
| Turnaround Time | 3 to 4 weeks | 5 to 6 weeks |
| Price (AED) | 2,800 | 3,200–3,800 |
| Sample Acceptance | Whole blood, extracted DNA, or one drop on FTA card | Blood only |
2. Physician Insight & Safety Protocol
“Every result from the TGFB1 NGS test must be interpreted within the full clinical and family history. A positive finding confirms the diagnosis, but a negative result does not rule out other bone dysplasias. Always correlate with imaging and symptoms before finalising management.” – Dr. Prabhakar Reddy, DHA License No. 61713011
⚠️ Do not discontinue any prescribed medication or alter your child’s treatment plan without consulting your physician. This genetic test is a diagnostic aid, not a substitute for clinical judgement.
Exclusion Criteria & Red Flags
- Exclusion: Sample collected from a patient who has undergone allogeneic bone marrow transplant within the last six months (donor DNA may confound results).
- Exclusion: Blood sample drawn without prior genetic counselling appointment (as required by UAE Federal Decree-Law No. 41 of 2024).
- Emergency Red Flag: If the patient develops acute bone pain, pathological fracture, or neurological signs (e.g., cranial nerve compression), seek immediate hospital care; do not await test results.
Patient Preparation & Required Documents
A detailed clinical history, including symptom onset and progression, is mandatory. A formal genetic counselling session must be conducted prior to testing to draw and document a three‑generation pedigree chart of family members affected by TGFB1‑associated Camurati‑Engelmann disease. UAE law (Federal Decree-Law No. 41/2024, Art. 87) requires written informed consent for genetic analysis in minors; legal guardians must provide valid Emirates ID.
3. Patient FAQ & Clinical Guidance
Q: What does a positive TGFB1 NGS test mean for my child’s diagnosis?
A: A positive result confirms a disease‑causing variant in the TGFB1 gene, establishing a definitive molecular diagnosis of Camurati‑Engelmann disease when accompanied by characteristic clinical and radiological findings.
ج: تؤكد النتيجة الإيجابية وجود طفرة مسببة للمرض في جين TGFB1، مما يثبت تشخيص مرض كاموراتي‑إنجلمان جزيئيًا عند توافقها مع الأعراض السريرية والصور الشعاعية.
Q: How long does it take to receive the test report and who interprets it?
A: The NGS workflow and rigorous bioinformatics analysis require 3 to 4 weeks; the final report is reviewed and signed by a DHA‑licensed molecular geneticist and includes a clinical correlation note.
ج: يستغرق إعداد التقرير 3 إلى 4 أسابيع بسبب التحليل المعلوماتي الحيوي الدقيق، ويوقّعه أخصائي جينات جزيئية مرخص من هيئة الصحة بدبي مع ملاحظات ارتباط سريري.
Q: Will insurance cover this genetic in the UAE?
A: Many UAE insurers cover diagnostic genetic testing for suspected hereditary bone disorders when a physician’s referral and prior authorisation are provided; our support team verifies benefits directly via WhatsApp.
ج: تغطي شركات التأمين الإماراتية عادةً الفحوصات الجينية التشخيصية عند وجود إحالة طبية وموافقة مسبقة؛ ويتحقق فريق الدعم من التغطية عبر الواتساب مباشرة.
DHA Facility License No. 9834453 | ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | Data Protection per UAE PDPL & Federal Decree-Law No. 41/2024 (Art. 87) | CDS Law 2026 compliance for minors.
Home collection available daily 8 AM – 11 PM. WhatsApp: +971 54 548 8731. LOINC 82939-0
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians